Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials

International Journal of Cardiology

Volumn 210, Issue , 2016, Pages 19-24

  Benedetto, Umberto ^a   Gaudino, Mario ^b   Ng, Colin ^a   Biondi Zoccai, Giuseppe ^c,d   D'Ascenzo, Fabrizio ^e   Frati, Giacomo ^c,f   Girardi, Leonard N ^b   Angelini, Gianni D ^a   Taggart, David P ^g  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Department of Obstetrics Gynecology   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Eleonora Lonillard Spencer Cenci Foundation   (Italy)

^e CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^f IRCCS NEUROMED   (Italy)

^g OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CABG; Meta analysis; PCI

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN;

BARE METAL STENT; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY ARTERY SURGERY; DIABETES MELLITUS; DRUG ELUTING CORONARY STENT; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; NUMBERS NEEDED TO TREAT; PACLITAXEL ELUTING CORONARY STENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; REVIEW; RISK REDUCTION; SENSITIVITY ANALYSIS; SIROLIMUS ELUTING CORONARY STENT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; DRUG ELUTING STENT; HEART SURGERY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84964680957     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.02.090     Document Type: Article

References (15)

1. T. Palmerini, U. Benedetto, G. Biondi-Zoccai, and et al. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis J. Am. Coll. Cardiol. 65 2015 2496 2507
2. P.W. Serruys, M.C. Morice, and A.P. kappetein SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N. Engl. J. Med. 360 2009 961 972
3. S.J. Park, Y.H. Kim, D.W. Park, and et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease N. Engl. J. Med. 364 2011 1718 1727
4. R.F. Riley, C.W. Don, W. Powell, C. Maynard, and L.S. Dean Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes Circ. Cardiovasc. Qual. Outcomes 4 2011 193 197
5. G.S. Collins, and Y. Le Manach Comparing treatment effects between propensity scores and randomized controlled trials: improving conduct and reporting Eur. Heart J. 33 2012 Aug 1867 1869
6. A. Liberati, D.G. Altman, J. Tetzlaff, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann. Intern. Med. 151 2009 W65 W94
7. Review Manager (RevMan) [Computer Program]. Version 5.3 2014 The Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen
8. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 566
9. S.J. Park, J.M. Ahn, and Y.H. Kim BEST Trial Investigators Trial of everolimus-eluting stents or bypass surgery for coronary disease N. Engl. J. Med. 372 2015 1204 1212
10. S.J. Head, P.M. Davierwala, P.W. Serruys, and et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial Eur. Heart J. 35 2014 2821 2830
11. M.E. Farkouh, M. Domanski, and L.A. Sleeper FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N. Engl. J. Med. 367 2012 2375 2384
12. A. Kapur, R.J. Hall, I.S. Malik, and et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-Year results of the CARDia (Coronary artery revascularization in diabetes) trial J. Am. Coll. Cardiol. 55 2010 432 440
13. M. Kamalesh, T.G. Sharp, and X.C. Tang VA CARDS Investigators Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes J. Am. Coll. Cardiol. 61 2013 808 816
14. J. Al Ali, C. Franck, K.B. Filion, and M.J. Eisenberg Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials JACC Cardiovasc. Interv. 7 2014 497 506
15. I. Sipahi, M.H. Akay, S. Dagdelen, A. Blitz, and C. Alhan Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era JAMA Intern. Med 174 2014 223 230 (1)